ALDX insider filings
Aldeyra Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen ALDX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings by 3 insiders — 217,500 shares, $140,275 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 200,000 shares @ $0.64 ($128,900) by DOUGLAS RICHARD, filed 2026-11-13.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| DOUGLAS RICHARD — Director | 1 | 1 leg · 200,000 sh · $128,900 | — | — |
| Alfieri Michael — Principal Financial Officer | 1 | 1 leg · 10,000 sh · $6,500 | — | — |
| DEPTULA-HICKS DARLENE M — Director | 1 | 1 leg · 7,500 sh · $4,875 | — | — |
Recent insider filings — Aldeyra Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | DEPTULA-HICKS DARLENE M — Director | Purchase (P): 7,500 @ $0.65 | EDGAR |
| 2026-11-13 | 4 | Alfieri Michael — Principal Financial Officer | Purchase (P): 10,000 @ $0.65 | EDGAR |
| 2026-11-13 | 4 | DOUGLAS RICHARD — Director | Purchase (P): 200,000 @ $0.64 | EDGAR |
| 2026-06-11 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Clark William D — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Walker Neal — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Bronstein Ben — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 5,309 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Phillips Gary M. — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 6,636 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | DEPTULA-HICKS DARLENE M — Director | Grant/award (A): 84,557 (derivative) @ $0 · Grant/award (A): 9,756 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 19,909 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Brady Todd C — President and CEO, Director | Purchase (P): 250,000 @ $1.67 | EDGAR |
| 2026-03-31 | 4 | Brady Todd C — President and CEO, Director | Grant/award (A): 1,880,510 (derivative) @ $0 · Grant/award (A): 632,318 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | DOUGLAS RICHARD — Director | Purchase (P): 70,000 @ $1.40 | EDGAR |
| 2026-03-19 | 4 | Alfieri Michael — Principal Financial Officer | Purchase (P): 5,000 @ $1.42 | EDGAR |
| 2025-08-15 | 4 | Alfieri Michael — Principal Financial Officer | Purchase (P): 2,500 @ $5.30 | EDGAR |
| 2025-08-13 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 22,073 @ $5.15 | EDGAR |
| 2025-06-12 | 4 | Walker Neal — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Bronstein Ben — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0 · Grant/award (A): 3,860 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | JOYCE MARTIN JOSEPH — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0 · Grant/award (A): 7,238 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Phillips Gary M. — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 4,825 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 14,476 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0 | EDGAR |
| 2025-04-18 | 4 | Clark William D — Director | Grant/award (A): 76,760 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Sale (S): 3,400,000 @ $1.42 | EDGAR |
| 2025-03-06 | 4 | Brady Todd C — President and CEO, Director | Grant/award (A): 809,710 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Machatha Stephen — Chief Development Officer | Grant/award (A): 202,427 (derivative) @ $0 | EDGAR |
| 2024-10-21 | 4 | Miller-Rich Nancy — Director | Purchase (P): 413 @ $12.81 · Purchase (P): 509 @ $10.13 | EDGAR |
| 2024-08-14 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 16,041 @ $4.74 | EDGAR |
| 2024-08-14 | 4 | Greenberg Bruce — See Remarks | Sale (S): 10,834 @ $4.74 | EDGAR |
| 2024-06-06 | 4 | Walker Neal — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Bronstein Ben — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 2,604 (derivative) @ $0 · Grant/award (A): 2,778 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | JOYCE MARTIN JOSEPH — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,215 (derivative) @ $0 · Grant/award (A): 5,209 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Phillips Gary M. — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 3,473 (derivative) @ $0 · Grant/award (A): 2,604 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 10,418 (derivative) @ $0 · Grant/award (A): 1,215 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4/A | Machatha Stephen — Chief Development Officer | Sale (S): 11,537 @ $3.16 | EDGAR |
| 2024-04-17 | 4/A | Greenberg Bruce — See Remarks | Sale (S): 13,201 @ $3.41 | EDGAR |
| 2024-04-08 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 140,281 @ $4.67 · Purchase (P): 37,712 @ $4.74 | EDGAR |
| 2024-04-03 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 8,374 @ $3.25 · Purchase (P): 186,051 @ $3.44 · Purchase (P): 309,847 @ $4.09 | EDGAR |
| 2024-03-12 | 4 | Greenberg Bruce — See Remarks | Sale (S): 13,201 @ $3.41 · Grant/award (A): 252,280 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 18,231 @ $3.41 · Sale (S): 11,537 @ $3.16 · Grant/award (A): 405,450 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Brady Todd C — President and CEO, Director | Sale (S): 97,914 @ $3.27 · Sale (S): 85,324 @ $3.05 · Grant/award (A): 1,081,201 (derivative) @ $0 | EDGAR |
| 2023-10-18 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Sale (S): 2,450,000 @ $1.60 · Sale (S): 306,499 @ $1.74 | EDGAR |
| 2023-09-11 | 4 | Brady Todd C — President and CEO, Director | Option exercise (M): 192,084 @ $0.55 · Option exercise (M): 32,953 @ $0.55 · Option exercise (M): 48,021 @ $0.55 · Tax withholding (F): 73,807 @ $7.22 · Option exercise (M): 192,084 (derivative) @ $0 · Option exercise (M): 32,953 (derivative) @ $0 · +1 more | EDGAR |
| 2023-09-11 | 4 | Phillips Gary M. — Director | Option exercise (M): 5,437 @ $0.55 · Option exercise (M): 5,437 (derivative) @ $0 | EDGAR |
| 2023-08-24 | 4 | Walker Neal — Director | Option exercise (M): 9,604 @ $0.55 · Option exercise (M): 9,604 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Walker Neal — Director | Grant/award (A): 21,222 (derivative) @ $0 · Grant/award (A): 915 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | JOYCE MARTIN JOSEPH — Director | Grant/award (A): 21,222 (derivative) @ $0 · Grant/award (A): 640 (derivative) @ $0 · Grant/award (A): 2,744 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Phillips Gary M. — Director | Grant/award (A): 21,222 (derivative) @ $0 · Grant/award (A): 1,829 (derivative) @ $0 · Grant/award (A): 1,372 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 21,222 (derivative) @ $0 · Grant/award (A): 5,488 (derivative) @ $0 · Grant/award (A): 640 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aldeyra Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-11-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-29 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs